Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10108	Companies
207152	Keywords
137287	Articles
109794	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 10/02/2025 at 06:30, 5 months 26 days ago

Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron. Commercial launch expected in Q4/2026

Formycon Regeneron Valorum Biologics Aflibercept Biosimilar Patent Disputes
BRIEF

published on 09/17/2025 at 16:00, 6 months 11 days ago

Formycon AG : Recherche et prévisions de performance actualisées

Prévisions De Revenus Formycon FYB202 Biosimilaires FYB206
BRIEF

published on 09/17/2025 at 16:00, 6 months 11 days ago

Formycon AG: Updated Research and Performance Forecast

Revenue Forecast Biosimilars Formycon FYB202 FYB206
PRESS RELEASE

published on 09/17/2025 at 15:55, 6 months 11 days ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates rating on Formycon AG (ISIN: DE000A1EWVY8) to Buy with a target price of €48. Analyst expects revenue to rebound in H2 and Q4 due to FYB202 and FYB206 developments

First Berlin Equity Research BUY Rating Formycon AG Update Target Price
BRIEF

published on 09/17/2025 at 06:35, 6 months 11 days ago

Horus Pharma rejoint la commercialisation du biosimilaire Eylea® de Formycon

Commercialisation Formycon Biosimilaire Baiama Horus Pharma
BRIEF

published on 09/17/2025 at 06:35, 6 months 11 days ago

Horus Pharma Joins Formycon's Eylea® Biosimilar Commercialization

Commercialization Biosimilar Formycon Baiama Horus Pharma
PRESS RELEASE

published on 09/17/2025 at 06:30, 6 months 11 days ago

Horus Pharma becomes additional commercialization partner for Formycon's Eylea® biosimilar FYB203 in selected European countries under the brand name Baiama®
Horus Pharma partners with Formycon for Eylea biosimilar commercialization in Europe under Baiama brand. Agreement includes upfront payments and royalties for Klinge. Aflibercept treats nAMD

Agreement Formycon Eylea Biosimilar Horus Pharma Baiama Brand
BRIEF

published on 08/13/2025 at 06:35, 7 months 15 days ago

Formycon Affirms Full-Year Outlook After Strategic Developments

Formycon AG Corporate Bond Biosimilar Market 2025 Financial Guidance FYB202 & FYB206
BRIEF

published on 08/13/2025 at 06:35, 7 months 15 days ago

Formycon confirme ses perspectives pour l'ensemble de l'année après des développements stratégiques

Formycon AG Obligations D'entreprise Orientations Financières 2025 Marché Des Biosimilaires FYB202 Et FYB206
PRESS RELEASE

published on 08/13/2025 at 06:30, 7 months 15 days ago

Formycon confirms full-year guidance following business development in line with plan – working capital raised
Formycon AG confirms full-year guidance with successful business development. Working capital raised through oversubscribed corporate bond. Strong second half expected

Working Capital Business Development Formycon AG Corporate Bond Full-year Guidance

Accesswire

Published on 03/28/2026 at 01:00, 15 hours 21 minutes ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 15 hours 26 minutes ago

Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 15 hours 31 minutes ago

"Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 17 hours 36 minutes ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 17 hours 51 minutes ago

Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property

View all ACCESSWIRE

EQS Group

Published on 03/28/2026 at 10:05, 6 hours 16 minutes ago

Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 7 hours 24 minutes ago

Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 14 hours 39 minutes ago

EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 18 hours 23 minutes ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 18 hours 23 minutes ago

Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025

Les Echos

Published on 03/28/2026 at 07:00, 9 hours 21 minutes ago

Groupe DLSI - Résultat 2025
Published on 03/27/2026 at 19:06, 21 hours 15 minutes ago

Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 19:06, 21 hours 15 minutes ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 21 hours 29 minutes ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 21 hours 29 minutes ago

Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025

View all LES ECHOS COMFI WIRE